• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cybin Inc (NY: CYBN )

    10.12 +0.13 (+1.30%)
    Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 60,391
    Open 10.03
    Bid (Size) 9.710 (1)
    Ask (Size) 10.12 (6)
    Prev. Close 9.990
    Today's Range 9.845 - 10.15
    52wk Range 6.500 - 22.31
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Present Advancements in Mental Health Treatment at Milken Institute Summit
    Via Investor Brand Network
    Cybin to Participate at the 2024 Milken Institute Future of Health Summit
    From Cybin Inc.
    Via Business Wire

    Performance

    YTD
    -33.42%
    -33.42%
    1 Month
    +9.41%
    +9.41%
    3 Month
    +0.50%
    +0.50%
    6 Month
    -27.63%
    -27.63%
    1 Year
    -53.28%
    -53.28%

    More News

    Read More
    BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Granted Patent for Lead Candidates in CYB005 Program
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
    Via InvestorPlace
    Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
    From Cybin Inc.
    Via Business Wire
    EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside Chat
    Via Investor Brand Network
    Exposures Product Safety
    Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
    From Cybin Inc.
    Via Business Wire
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Strengthens Its Clinical Development Team
    Via Investor Brand Network
    Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
    From Cybin Inc.
    Via Business Wire
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Chief Medical Officer to Participate in a Panel Discussion at Upcoming Summit
    Via Investor Brand Network
    Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
    From Cybin Inc.
    Via Business Wire
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Reports on Status of Key Clinical Milestones
    Via Investor Brand Network
    Cybin Provides Corporate Update on Upcoming Clinical Milestones
    From Cybin Inc.
    Via Business Wire
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Completes 38-for-1 Share Consolidation
    Via Investor Brand Network
    Cybin Announces Completion of Previously Announced Share Consolidation
    From Cybin Inc.
    Via Business Wire
    Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    From Cybin Inc.
    Via Business Wire
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports on Annual and Special Meeting of Shareholders, Share Consolidation
    Via Investor Brand Network
    Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation
    From Cybin Inc.
    Via Business Wire
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial
    Via Investor Brand Network
    Exposures Product Safety
    Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
    From Cybin Inc.
    Via Business Wire
    BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
    From Cybin Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.